Mark Boothby

10.6k total citations · 1 hit paper
139 papers, 8.3k citations indexed

About

Mark Boothby is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mark Boothby has authored 139 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Immunology, 44 papers in Molecular Biology and 42 papers in Oncology. Recurrent topics in Mark Boothby's work include Immune Cell Function and Interaction (66 papers), T-cell and B-cell Immunology (41 papers) and NF-κB Signaling Pathways (30 papers). Mark Boothby is often cited by papers focused on Immune Cell Function and Interaction (66 papers), T-cell and B-cell Immunology (41 papers) and NF-κB Signaling Pathways (30 papers). Mark Boothby collaborates with scholars based in United States, France and United Kingdom. Mark Boothby's co-authors include Ana L. Mora, Sung Hoon Cho, Nicole M. Chapman, Hongbo Chi, Irving Boime, Laurie H. Glimcher, Hsiou‐Chi Liou, Achsah Keegan, Shreevrat Goenka and Sebastian Joyce and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark Boothby

137 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic coordination of T cell quiescence and activation

2019 476 citations Mark Boothby et al. profile →

Peers

Countries citing papers authored by Mark Boothby

Since Specialization

Citations

This map shows the geographic impact of Mark Boothby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Boothby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Boothby more than expected).

Fields of papers citing papers by Mark Boothby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Boothby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Boothby. The network helps show where Mark Boothby may publish in the future.

Co-authorship network of co-authors of Mark Boothby

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Boothby. A scholar is included among the top collaborators of Mark Boothby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Boothby. Mark Boothby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The nutrient-sensing Rag-GTPase complex in B cells controls humoral immunity via TFEB/TFE3-dependent mitochondrial fitness 2024 ·Nature Communications ·Xingxing Zhu, Yue Wu, Yanfeng Li, Xian Zhou, Jens O. Watzlawik, Yin Chen, Ariel Raybuck, Daniel D. Billadeau, Virginia Smith Shapiro, Wolfdieter Springer, Jie Sun, Mark Boothby, Hu Zeng	2
2	PARP14 Contributes to the Development of the Tumor-Associated Macrophage Phenotype 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), Zsolt Regdon, Anett Mázló, (unknown), Attila Bácsi, (unknown), Csaba Hegedűs, Mark Boothby, (unknown), Dana Ferraris, H. Schüler, László Virág	6
3	Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production 2023 ·Journal of Clinical Investigation ·Shyamala Thirunavukkarasu, Mushtaq Ahmed, Bruce A. Rosa, Mark Boothby, Sung Hoon Cho, Javier Rangel‐Moreno, Stanley Kimbung Mbandi, Valérie Schreiber, Ananya Gupta, Joaquı́n Zúñiga, Makedonka Mitreva, Deepak Kaushal, Thomas J. Scriba, Shabaana A. Khader	12
4	Discovering New Lipidomic Features Using Cell Type Specific Fluorophore Expression to Provide Spatial and Biological Specificity in a Multimodal Workflow with MALDI Imaging Mass Spectrometry 2020 ·Analytical Chemistry ·(unknown), Sung Hoon Cho, Nathan Heath Patterson, Raf Van de Plas, Jeffrey M. Spraggins, Mark Boothby, Richard M. Caprioli	27
5	PARP14 Controls the Nuclear Accumulation of a Subset of Type I IFN–Inducible Proteins 2018 ·The Journal of Immunology ·Greta Caprara, Elena Prosperini, Viviana Piccolo, Gianluca Sigismondo, (unknown), Alessandro Cuomo, Mark Boothby, María Rescigno, Tiziana Bonaldi, Gioacchino Natoli	61
6	PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses 2016 ·Clinical Cancer Research ·Jiqing Sai, Philip Owens, Sergey V. Novitskiy, Oriana E. Hawkins, Anna E. Vilgelm, Jinming Yang, Tammy Sobolik, Nicole Lavender, Andrew C. Johnson, Colt M. McClain, Gregory D. Ayers, Mark C. Kelley, Melinda E. Sanders, Ingrid A. Mayer, Harold L. Moses, Mark Boothby, Ann Richmond	89
7	Myeloid IKKβ Promotes Antitumor Immunity by Modulating CCL11 and the Innate Immune Response 2014 ·Cancer Research ·Jinming Yang, Oriana E. Hawkins, Whitney Barham, Pavlo Gilchuk, Mark Boothby, Gregory D. Ayers, Sebastian Joyce, Michael Karin, Fiona E. Yull, Ann Richmond	36
8	Ikk4a/Arf Inactivation with Activation of the NF-κB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma 2012 ·Cancer Research ·Jinming Yang, Sara Kantrow, Jiqing Sai, Oriana E. Hawkins, Mark Boothby, Gregory D. Ayers, Eric D. Young, Elizabeth G. Demicco, Alexander J. Lazar, Dina Lev, Ann Richmond	30
9	Sequence Motifs in IL-4Rα Mediating Cell-Cycle Progression of Primary Lymphocytes 2005 ·The Journal of Immunology ·Linda M. Stephenson, Do‐Sim Park, Ana L. Mora, Shreevrat Goenka, Mark Boothby	17
10	Opposing Roles for RelB and Bcl-3 in Regulation of T-Box Expressed in T Cells, GATA-3, and Th Effector Differentiation 2005 ·The Journal of Immunology ·(unknown), Chris Hunter, Hsiou‐Chi Liou, Ulrich Siebenlist, Mark Boothby	73
11	NF-κB Controls Cell Fate Specification, Survival, and Molecular Differentiation of Immunoregulatory Natural T Lymphocytes 2004 ·The Journal of Immunology ·Aleksandar K. Stanic, Jelena S. Bezbradica, Jang‐June Park, Naoto Matsuki, Ana L. Mora, Luc Van Kaer, Mark Boothby, Sebastian Joyce	88
12	Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor 2003 ·Journal of Clinical Investigation ·Li Yang, Noboru Yamagata, Rajwardhan Yadav, Suzanne Brandon, Regina Courtney, Jason D. Morrow, Yu Shyr, Mark Boothby, Sebastian Joyce, David P. Carbone, Richard Breyer	204
13	Recall Helper T Cell Response 2003 ·American Journal of Respiratory and Critical Care Medicine ·Mark Aronica, Susan A. McCarthy, Shadi Swaidani, Daphne B. Mitchell, (unknown), James R. Sheller, Mark Boothby	19
14	New Programming of IL-4 Receptor Signal Transduction in Activated T Cells: Stat6 Induction and Th2 Differentiation Mediated by IL-4Rα Lacking Cytoplasmic Tyrosines 2003 ·The Journal of Immunology ·Ana L. Mora, Linda M. Stephenson, (unknown), Jeehee Youn, Achsah Keegan, Mark Boothby	9
15	Inhibition of NF-κB Activity in T and NK Cells Results in Defective Effector Cell Expansion and Production of IFN-γ Required for Resistance to Toxoplasma gondii 2003 ·The Journal of Immunology ·Cristina M. Tato, Alejandro V. Villarino, Jorge Caamaño, Mark Boothby, Christopher A. Hunter	47
16	T Cell-Intrinsic Requirement for NF-κB Induction in Postdifferentiation IFN-γ Production and Clonal Expansion in a Th1 Response 2003 ·The Journal of Immunology ·(unknown), Mark Aronica, Fuping Zhang, (unknown), Sarah A. Stanley, (unknown), Linda M. Stephenson, (unknown), Susan A. McCarthy, Ana L. Mora, Mark Boothby	82
17	A Minimal IFN-γ Promoter Confers Th1 Selective Expression 2002 ·The Journal of Immunology ·Mohammed Soutto, Feng Zhang, (unknown), (unknown), Mark Boothby, Thomas M. Aune	39
18	NF-κB/Rel Participation in the Lymphokine-Dependent Proliferation of T Lymphoid Cells 2001 ·The Journal of Immunology ·Ana L. Mora, Jeehee Youn, Achsah Keegan, Mark Boothby	42
19	Inefficient ZAP-70 Phosphorylation and Decreased Thymic Selection In Vivo Result from Inhibition of NF-κB/Rel 2001 ·The Journal of Immunology ·Ana L. Mora, Sarah A. Stanley, (unknown), Andrew C. Chan, Mark Boothby	26
20	Inhibition of NF-κB-Dependent T Cell Activation Abrogates Acute Allograft Rejection 2001 ·The Journal of Immunology ·Patricia W. Finn, James R. Stone, Mark Boothby, David L. Perkins	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact